Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting.
Saved in:
| Title: | Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting. |
|---|---|
| Authors: | Kato S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA., Li B; Ambry Genetics, Aliso Viejo, CA, USA., Adashek JJ; Department of Internal Medicine, University of South Florida, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Cha SW; Ambry Genetics, Aliso Viejo, CA, USA., Bianchi-Frias D; Ambry Genetics, Aliso Viejo, CA, USA., Qian D; Ambry Genetics, Aliso Viejo, CA, USA., Kim L; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA., So TW; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA., Mitchell M; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA., Kamei N; Bio Advanced Technology Division, Corporate R&D Headquarters, Konica Minolta, Inc, Tokyo, Japan., Hoiness R; Ambry Genetics, Aliso Viejo, CA, USA., Hoo J; Ambry Genetics, Aliso Viejo, CA, USA., Gray PN; Ambry Genetics, Aliso Viejo, CA, USA., Iyama T; Bio Advanced Technology Division, Corporate R&D Headquarters, Konica Minolta, Inc, Tokyo, Japan., Kashiwagi M; Bio Advanced Technology Division, Corporate R&D Headquarters, Konica Minolta, Inc, Tokyo, Japan., Lu HM; Ambry Genetics, Aliso Viejo, CA, USA., Kurzrock R; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA. |
| Source: | Oncoimmunology [Oncoimmunology] 2022 Mar 29; Vol. 11 (1), pp. 2052410. Date of Electronic Publication: 2022 Mar 29 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
